{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Lake Oswego",
      "state": "OR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98494",
      "recalling_firm": "HTO Nevada Inc. dba Kirkman",
      "address_1": "6400 Rosewood St",
      "address_2": "N/A",
      "postal_code": "97035-5392",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide within the U.S",
      "recall_number": "D-0387-2026",
      "product_description": "MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%),  1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.",
      "product_quantity": "243 bottles",
      "reason_for_recall": "Stability Data Does Not Support Expiry Date.",
      "recall_initiation_date": "20260218",
      "center_classification_date": "20260305",
      "report_date": "20260311",
      "code_info": "Lot #: 795CP-0005, Exp. Date 06/30/2026"
    }
  ]
}